Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Tobias Hestler
Age : 50
Country of residence : Unknown
Linked companies : Haleon plc

Summary 
Mr. Tobias H. Hestler is a Chief Financial Officer & Executive Director at Haleon Plc.

He is on the Board of Directors at Haleon Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd., GlaxoSmithKline Consumer Healthcare Finance Ltd., Stiefel Consumer Healthcare (UK) Ltd., GlaxoSmithKline Consumer Healthcare (UK) IP Ltd., GlaxoSmithKline Consumer Healthcare Finance No. 2 Ltd., GlaxoSmithKline Consumer Healthcare Holdings (No. 2) Ltd. and GlaxoSmithKline Consumer Healthcare Holdings Ltd. Mr. Hestler was previously employed as a Chief Financial Officer by Sandoz International GmbH and a Chief Financial Officer & Director-Administration by Hexal AG.




Current positions of Tobias Hestler 
Tobias Hestler : Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/26LVMH's Arnault brushes off succession question
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
02/01Sony Group CFO Totoki to succeed Yoshida as president - Nikkei
RE
More news


© 2023 People and Ownership :   
Tobias Hestler : Connections 


Latest news about Tobias Hestler 
2022Transcript : Haleon plc, Q3 2022 Sales/ Trading Statement Call, Nov 10, 2022
CI
2022Transcript : Haleon plc, H1 2022 Earnings Call, Sep 20, 2022
CI
2022Transcript : Haleon plc, H1 2022 Pre Recorded Earnings Call, Sep 20, 2022
CI
2022GSK plc completed the Spin-Off of Haleon plc (LSE:HLN).
CI
2022Transcript : GSK plc Presents at 19th annual dbAccess Global Consumer Conference 2022, Jun-14-2022 03:45 PM
CI
2022Pfizer to sell stake in GSK's consumer health business after it lists
RE
2022Glaxosmithkline plc Announces Appointments to Designate Haleon Board
CI
More news